Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Net sales $ 154,153 $ 131,807 $ 298,766 $ 262,388
Cost of sales 52,319 43,664 99,064 86,901
Gross margin 101,834 88,143 199,702 175,487
Operating expenses:        
Selling, general and administrative 63,775 56,981 122,064 102,405
Research and development 13,911 13,281 27,459 26,046
Total operating expenses 77,686 70,262 149,523 128,451
Operating income 24,148 17,881 50,179 47,036
Other income (expense) (2,417) (2,693) (5,480) (4,064)
Earnings before income taxes 21,731 15,188 44,699 42,972
Income tax expense (benefit) (27,116) 7,721 (20,011) 16,663
Net earnings 48,847 7,467 64,710 26,309
Other comprehensive income:        
Foreign currency translation adjustments 1,524 (10,066) 8,492 (13,301)
Unrealized gain (loss) on available-for-sale investments, net of tax of $799, $(1,889), $5,375, and $(2,060), respectively (8,582) 6,778 (16,374) 16,486
Other comprehensive (loss) income (7,058) (3,288) (7,882) 3,185
Comprehensive income (loss) $ 41,789 $ 4,179 $ 56,828 $ 29,494
Earnings per share:        
Basic (in dollars per share) $ 1.30 $ 0.20 $ 1.73 $ 0.70
Diluted (in dollars per share) 1.29 0.20 1.71 0.70
Cash dividends per common share: (in dollars per share) $ 0.32 $ 0.32 $ 0.64 $ 0.64
Weighted average common shares outstanding:        
Basic (in shares) 37,449 37,308 37,412 37,294
Diluted (in shares) 37,926 37,478 37,816 37,475